Efficacy of a Mesotherapy-Inspired Cosmetic Serum vs. Meso-Injections: Proteomic Insights and Clinical Results

Aesthetic mesotherapy—the subcutaneous injection of key ingredients for cellular function—has gained popularity as a skin rejuvenation treatment. We developed a cosmetic serum, incorporating 11 ingredients frequently used in meso-injections that are partially encapsulated in multilamellar vesicles. We evaluated the ingredients, and their formulation into a topical serum and in mesotherapy injections, for their efficacy at modulating skin rejuvenation in vitro, ex vivo and in vivo. Proteomic profiling of skin explants subjected to a meso-injection identified 47 differentially regulated proteins, whereas topical ingredient applications modulated 149 proteins, predominantly by upregulating them. These proteins mapped to gene ontology pathways relating to ER-Golgi transport, protein trafficking, energy metabolism, integrin signalling, extracellular matrix organisation, and regulation of cell proliferation. The impact of some ingredient classes appeared pathway-specific, while broader responses possibly reflected synergistic interactions. Consistently, topical ingredient application increased ATP levels in reconstructed skin, suggesting enhanced metabolic activity. Clinically, twice-daily serum applications over 63 days yielded improvements in skin smoothness, complexion radiance and complexion homogeneity comparable to those observed after three meso-injections. However, results appeared to vary with age, and the combination of serum application with meso-injection may offer benefits, particularly for skin firmness, acting in combination with mesotherapy to improve skin quality.